Dana J. Moss - 11 Jul 2023 Form 4 Insider Report for NAVIDEA BIOPHARMACEUTICALS, INC.

Role
Director
Signature
/s/ Gioia Gentile for Dana J. Moss, by power of attorney
Issuer symbol
N/A
Transactions as of
11 Jul 2023
Net transactions value
$0
Form type
4
Filing time
17 Jul 2023, 18:02:51 UTC
Next filing
20 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NAVB Common Stock Award $0 +250,000 $0.000000 250,000 11 Jul 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares granted pursuant to Issuer's 2014 Amended and Restated Stock Incentive Plan.